Meaningful Reduction of Hepatocellular Carcinoma Risk In Patients with Chronic Hepatitis C Who Received Pegile Interferon Plus Ribavirin Therapy: Two tertiary Center Experience.


Şirin G. , Şentürk Ö., Çelebi A. , Yılmaz H. , Sezikli M., Hülagü S.

23 th United European Gastroenterology Week, Barcelona, Spain, 24 - 28 October 2015

  • Publication Type: Conference Paper / Summary Text
  • City: Barcelona
  • Country: Spain